SLA 0.00% $3.34 silk laser australia limited

nope, you argued that ropren would never be given approval by...

  1. 1,059 Posts.
    nope, you argued that ropren would never be given approval by the RMOH and would demand an expensive phase 3 clinical trial. a manufacturing license is a completely different issue. dont worry tharlow, i dont think anyone here expected you to live up to you word. you have zero credibility. back on igniore for you.
 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.